Venture-Ready Technologies are some of the University of Rochester’s most promising inventions. We believe the technologies and innovations described below have significant commercial potential. Some of these items could fit nicely into a company’s existing intellectual property portfolio to enhance a product line or help launch a new one. Others represent platform technologies that could constitute the foundation of a new startup company. In either case, we invite you to peruse the following which will be updated periodically with new featured patents. If anything is of interest, please contact UR Ventures.
This invention describes a novel vaccine against type 1 diabetes.
A biomarker to save time and money in the treatment of arthritis.
A method to enhance the effects of deep brain stimulation.
A safe and effective therapy based on the bacterial AvrA peptide for the treatment of inflammatory bowel and celiac diseases.
A vaccine effective against all four strains of the Dengue virus.
A method to suppress premature stop codons in order to generate full-length mRNA using target-specific guide mRNAs.
A protein/peptide-based therapy for the prevention and treatment of obesity with desirable side effect profile.
A method of remyelinating axons using oligodendrocyte progenitor cells.